TITLE

Review: Vaccination reduces the incidence of serologically confirmed influenza in healthy adults

PUB. DATE
May 2005
SOURCE
ACP Journal Club;May/Jun2005, Vol. 142 Issue 3, p70
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article presents a study, which reports that vaccination reduces the incidence of serologically confirmed influenza (SCI) in healthy adults. The study method consisted of quasirandomized or randomized controlled trials that evaluated the effectiveness of influenza vaccines for protection from exposure to naturally occurring influenza in healthy persons 14 to 60 years age. The main results depicted that for influenza vaccine rates of clinically defined influenza and SCI were lower in the vaccine group than in the placebo group.
ACCESSION #
17116534

 

Related Articles

  • Inactivated influenza vaccine prevented influenza in healthy adults. Ohmit, S. E.; Victor, J. C.; Rotthoff, J. R. // ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p60 

    The article presents a study which examines the prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. Two placebo groups were combined for the efficacy analysis. The inactivated influenza vaccine had a higher rate of vaccine efficacy than did placebo for each...

  • Inactivated influenza vaccine prevented influenza in healthy adults: COMMENTARY. Granwehr, Bruno // ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p60 

    The article comments on the research conducted by S. E. Ohmit and his colleagues, which addresses the efficacy of intranasal live attenuated and injected inactivated influenza vaccines in a community-based trial. The author stressed that the increased interest in universal influenza vaccination...

  • Prevention of Symptomatic Seasonal Influenza in 2005-2006 by Inactivated and Live Attenuated Vaccines. Ohmit, Suzanne E.; Victor, John C.; Teich, Esther R.; Truscon, Rachel K.; Rotthoff, Judy R.; Newton, Duane W.; Campbell, Sarah A.; Boulton, Matthew L.; Monto, Arnold S. // Journal of Infectious Diseases;8/1/2008, Vol. 198 Issue 3, p312 

    Background. The efficacy of influenza vaccines may vary annually. In 2004-2005, when antigenically drifted viruses were circulating, a randomized, placebo-controlled trial involving healthy adults showed that inactivated vaccine appeared to be efficacious, whereas live attenuated vaccine...

  • Frequency of Adverse Reactions to Influenza Vaccine in the Elderly. Margolis, Karen L.; Nichol, Kristin L.; Poland, Gregory A.; Pluhar, Robert E. // JAMA: Journal of the American Medical Association;9/5/90, Vol. 264 Issue 9, p1139 

    Details a study which compared the frequency of adverse reactions following administration of 1988-1989 trivalent split-antigen influenza vaccine and saline placebo among the elderly in the U.S. Data from outpatient veterans; Post-injection symptoms; Safety of administering influenza vaccine.

  • Prevention of Symptomatic Seasonal Influenza in 2005-2006 by Inactivated and Live Attenuated Vaccines. Ohmit, Suzanne E.; Victor, John C.; Teich, Esther R.; Truscon, Rachel K.; Rotthoff, Judy R.; Newton, Duane W.; Campbell, Sarah A.; Boulton, Matthew L.; Monto, Arnold S. // Journal of Infectious Diseases;8/1/2008, Vol. 198 Issue 3, p312 

    Background. The efficacy of influenza vaccines may vary annually. In 2004-2005, when antigenically drifted viruses were circulating, a randomized, placebo-controlled trial involving healthy adults showed that inactivated vaccine appeared to be efficacious, whereas live attenuated vaccine...

  • Reports of Expired Live Attenuated Influenza Vaccine Being Administered -- United States, 2007-2014. Haber, Penina; Schembri, Christopher P.; Lewis, Paige; Hibbs, Beth; Shimabukuro, Tom // MMWR: Morbidity & Mortality Weekly Report;9/5/2014, Vol. 63 Issue 35, p773 

    The article presents information on reports of expired live attenuated influenza vaccine (LAIV) administered between 2007-2014 in the U.S. There are two types of vaccine that are approved in the U.S. including injectable inactivated influenza vaccine (IIV) and LAIV. According to a report, from...

  • Efficacy of a recombinant equine infleunza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom. Edlund Toulemonde, C.; Daly, J.; Sindle, T.; Guigal, P. M.; Audonnet, J. C.; Minke, J. M. // Veterinary Record: Journal of the British Veterinary Association;3/19/2005, Vol. 156 Issue 12, p367 

    Fifteen influenza-naive Welsh mountain ponies were randomly assigned to three groups of five. A single dose of a recombinant ALVAC vaccine was administered intramuscularly to five of the ponies, two doses, administered five weeks apart, were administered to five, and the other five served as...

  • Flu shot success.  // New Scientist;9/24/2005, Vol. 187 Issue 2518, p4 

    This article discusses various ongoing efforts to develop flu vaccine. There is increasing evidence that the vaccination could save lives, especially if given to people over 65 and those likely to come into contact with them. Determining the benefits of flu shots has been difficult, partly...

  • Flu vaccine grown inside insect cells shows promise.  // PharmaWatch: Biotechnology;May2007, Vol. 6 Issue 5, p6 

    The article reports on the discovery of an alternative to traditional egg based method of developing influenza vaccines. Researchers at the University of Rochester evaluated an excremental influenza vaccine consisting of recombinant hemagglutinin expressed in yellow striped caterpillars by a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics